全国职称英语考试 卫生类 B 纯英版完形填空文章背诵版.doc
《全国职称英语考试 卫生类 B 纯英版完形填空文章背诵版.doc》由会员分享,可在线阅读,更多相关《全国职称英语考试 卫生类 B 纯英版完形填空文章背诵版.doc(5页珍藏版)》请在三一办公上搜索。
1、(重重点)第九篇 The Case of the Disappearing FingerprintsOne useful anti-cancer drug can effectively erase the whorls and other characteristic marks that give people their distinctive fingerprints. Losing _them_ could become troublesome. A case released online in a letter by Annals of Oncology indicates ho
2、w big a problem_ of losing fingerprints is.Eng-Haut Tan, a Singapore-based medical doctor describes a 62-year old man who has used capacitating totreat his nasopharyngeal cancer(NPC). After three years on the _drug_ ,the patient decided to visit U. S. relatives last December. But he was stopped by U
3、. S. customs officials for_ 4 hours after entering the country when those officials couldnt get fingerprints from the man. There were no distinctive swirly marks appearing from his index finger.U. S. customs has been fingerprinting incoming foreign visitors for years, Tan says. Their index fingers a
4、re printed_ and screened against digital files of the fingerprints of bad guys terrorists and potential criminals that our federal guardians have been tasked with keeping out of (固定搭配)the country. Unfortunately, for the Singaporean traveler,one potential side effect of his drug treatment is a smooth
5、ing of the tissue on the finger pads. Hence,no fingerprints. “It is uncertain when fingerprint loss will being_ to take place in patients who are taking capacitating,” Tan points out. So he cautions any physicians who _prescribe_ the drug to provide their patients with a doctors note pointing out th
6、at their medicine may cause fingerprints to disappear.Eventually, the Singapore traveler made it into the United States. I guess the name on his passport didnt raise any red flags. But he,also now got the explanatory doctors note and wont leave home _without_ it.By the way, maybe the Food and Drug A
7、dministration, which approved use of the drug 11 years ago,should consider updating_ its list of side effects associated with this medicine. The current list does note that patients may experience vomiting, stomachs pain and some other side effects. But no where does it mention the potential for los
8、s of fingerprints.(重重点)第六篇 Once-daily Pill Could Simplify HIV Treatment Bristol-Myers Myers Squibb and Gilead Sciences have combined many HIV drugs into a single pill sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and HIV/AIDS, for example, are all treated with
9、combinations of drugs. But that can mean a lot of pills to take. It would be simpler if drug companies combined all the medicines into a single pill, taken just once a day. Now, two companies say they have done that for people just starting treatment for HIV, the virus that causes AIDS. The companie
10、s are Bristol-Myers Squibb and Gilead Sciences. They have developed a single pill that combines three drugs currently on the market. Bristol-Myers Squibb sells one of them under the name of Sustiva.Gilead combined the others, Emtriva and Viread, into a single pill in two thousand four(2004). Combini
11、ng drugs involves more than technical issues. It also involves issues of competition if the drugs are made by different companies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of HIV. In January the New England Journal o
12、f Medicine5 published a study of the new pill. Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed HIV levels in more patients an
13、d with fewer side effects. Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmith Kline. Glaxo Smith Kline reacted to the
14、 findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies. The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developin
15、g countries. They plan in the next few months to ask the United States Food and Drug Administration(FDA)to approve the new pill. There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth dis
16、orders. Experts say more than forty million people around the world are living with HIV(重重点)第十篇 Hospital MistreatmentAccording to a study, most medical interns report experiencing mistreatment, including humiliation by senior doctors, being threatened, or physical abuse in their first year out of me
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 全国职称英语考试 卫生类 纯英版完形填空文章背诵版 全国 职称 英语考试 卫生 纯英版完形 填空 文章 背诵
链接地址:https://www.31ppt.com/p-4072485.html